Literature DB >> 25944326

Implication of the recent positive endovascular intervention trials for organizing acute stroke care: European perspective.

Turgut Tatlisumak1.   

Abstract

Timely recanalization leads to improved patient outcomes in acute ischemic stroke. Recent trial results demonstrated a strong benefit for endovascular therapies over standard medical care in patients with acute ischemic stroke and a major intracranial artery occlusion≤6 hours or even beyond from symptom onset and independent of patients' age. Previous studies have shown the benefit of intravenous thrombolysis that had gradually, albeit slowly, reshaped acute stroke care worldwide. Now, given the superior benefits of endovascular intervention, the whole structure of acute stroke care needs to be reorganized to meet patient needs and to deliver evidence-based treatments effectively. However, a blueprint for success with novel stroke treatments should be composed of numerous elements and requires efforts from various parties. Regarding the endovascular therapies, the strengths of Europe include highly organized democratic society structures, high rate of urbanization, well-developed revenue-based healthcare systems, and high income levels, whereas the obstacles include the east-west disparity in wealth, the ongoing economic crisis hindering spread of fairly costly new treatments, and the quickly aging population putting more demands on health care in general. Regional and national plans for covering whole population with 24/7 adequate acute stroke care are necessary in close cooperation of professionals and decision-makers. Europe-wide new training programs for expert physicians in stroke care should be initiated shortly. European Stroke Organisation has a unique role in providing expertise, consultation, guidelines, and versatile training in meeting new demands in stroke care. This article discusses the current situation, prospects, and challenges in Europe offering personal views on potential solutions.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  organization; thrombectomy; thrombolysis

Mesh:

Year:  2015        PMID: 25944326     DOI: 10.1161/STROKEAHA.115.008386

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  Endovascular Thrombectomy in Acute Ischemic Stroke: Outcome in Referred Versus Directly Admitted Patients.

Authors:  Philipp Bücke; Marta Aguilar Pérez; Elisabeth Schmid; Christian H Nolte; Hansjörg Bäzner; Hans Henkes
Journal:  Clin Neuroradiol       Date:  2017-01-31       Impact factor: 3.649

Review 2.  Quantitative sodium MR imaging: A review of its evolving role in medicine.

Authors:  Keith R Thulborn
Journal:  Neuroimage       Date:  2016-11-24       Impact factor: 6.556

Review 3.  Utilizing Implementation Science to Bridge Cerebrovascular Health Disparities: a Local to Global Perspective.

Authors:  Fred Stephen Sarfo; Bruce Ovbiagele
Journal:  Curr Neurol Neurosci Rep       Date:  2022-04-06       Impact factor: 6.030

Review 4.  Thrombectomy for Acute Ischemic Stroke: Recent Insights and Future Directions.

Authors:  Aravind Ganesh; Mayank Goyal
Journal:  Curr Neurol Neurosci Rep       Date:  2018-07-23       Impact factor: 5.081

Review 5.  [From stroke to reperfusion : How can we be faster?]

Authors:  F Härtig; J Purrucker; C Hametner; S Poli
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-10-12       Impact factor: 0.840

6.  Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke.

Authors:  Gregory Y H Lip; Deirdre A Lane; Radosław Lenarczyk; Giuseppe Boriani; Wolfram Doehner; Laura A Benjamin; Marc Fisher; Deborah Lowe; Ralph L Sacco; Renate Schnabel; Caroline Watkins; George Ntaios; Tatjana Potpara
Journal:  Eur Heart J       Date:  2022-07-07       Impact factor: 35.855

7.  Endovascular stroke treatment in a small-volume stroke center.

Authors:  Gry N Behzadi; Lars Fjetland; Rajiv Advani; Martin W Kurz; Kathinka D Kurz
Journal:  Brain Behav       Date:  2017-02-28       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.